CN104127854A - Chinese herbal medicine for treating migraine - Google Patents
Chinese herbal medicine for treating migraine Download PDFInfo
- Publication number
- CN104127854A CN104127854A CN201410406929.4A CN201410406929A CN104127854A CN 104127854 A CN104127854 A CN 104127854A CN 201410406929 A CN201410406929 A CN 201410406929A CN 104127854 A CN104127854 A CN 104127854A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- rhizoma
- chinese herbal
- herbal medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a Chinese herbal medicine for treating migraine. The Chinese herbal medicine comprises the following components: 10-13 parts of heat-dispelling chrysanthemum, 16-19 parts of honey-fried licorice root, 8-11 parts of astragalus membranaceus, 3-6 parts of longan, 5-8 parts of feverfew, 12-15 parts of gingko, 14-17 parts of mentha longifolia, 21-24 parts of rosemary, 18-21 parts of wormwood, 24-27 parts of ligusticum wallichii, 30-33 parts of radix angelicae, 35-38 parts of radix paeoniae alba, 27-30 parts of radix bupleuri, 4-7 parts of rhizoma typhonii, 30-33 parts of angelica sinensis, 34-37 parts of concha haliotidis, 7-10 parts of uncaria, 9-12 parts of pinellia ternate and 17-20 parts of rhizoma zingiberis. The Chinese herbal medicine has the characteristic of being green, free of pollution, and free of a side effect, and has a good treatment effect, and the function of a human body can be adjusted.
Description
Technical field
The present invention relates to a kind of medical technical field, be specifically related to a kind of migrainous Chinese herbal medicine for the treatment of.
Background technology
At present, the migrainous medicament for the treatment of using on market adopts chemosynthesis composition and various extracting solution hybrid modulation to form mostly, thereby reach a migraine phenomenon that reduces or eliminate people, but this type of medicine all contains a large amount of negative harm conventionally, affects the physical function of human body.And because migraine kind is various, when using a kind of medicine, cannot effectively carry out for, result of use is not good enough.
Summary of the invention
The object of the present invention is to provide a kind of employing pure natural plant to make, green non-pollution, is used without any side effectsly, and each migrainoid phenomenon is had to good therapeutic effect, regulates the migrainous Chinese herbal medicine for the treatment of of function of human body simultaneously.
Technical scheme of the present invention is, a kind ofly treat migrainous Chinese herbal medicine, comprise and drive hot chrysanthemum, chryanthemum parthenium, Semen Ginkgo, lavender, Herba Rosmarini Officinalis, Folium Artemisiae Argyi, Rhizoma Chuanxiong, the Radix Angelicae Dahuricae, the Radix Paeoniae Alba, Radix Bupleuri, Rhizoma Typhonii, Radix Angelicae Sinensis, Concha Haliotidis, Ramulus Uncariae Cum Uncis, the Rhizoma Pinelliae and Rhizoma Zingiberis, each composition of the migrainous Chinese herbal medicine of described treatment by umber proportioning is: described in to drive hot chrysanthemum be 10-13 part, described Radix Glycyrrhizae Preparata is 16-19 part, the described Radix Astragali is 8-11 part, described Arillus Longan is 3-6 part, described chryanthemum parthenium is 5-8 part, described Semen Ginkgo is 12-15 part, described lavender is 14-17 part, described Herba Rosmarini Officinalis is 21-24 part, described Folium Artemisiae Argyi is 18-21 part, described Rhizoma Chuanxiong is 24-27 part, the described Radix Angelicae Dahuricae is 30-33 part, the described Radix Paeoniae Alba is 35-38 part, described Radix Bupleuri is 27-30 part, described Rhizoma Typhonii is 4-7 part, described when being classified as 30-33 part, described Concha Haliotidis is 34-37 part, described Ramulus Uncariae Cum Uncis is 7-10 part, the described Rhizoma Pinelliae is 9-12 part, described Rhizoma Zingiberis is 17-20 part.
In a preferred embodiment of the present invention, each composition of the migrainous Chinese herbal medicine of described treatment by the concrete proportioning of umber is: described in to drive hot chrysanthemum be 11 parts, described Radix Glycyrrhizae Preparata is 17 parts, the described Radix Astragali is 9 parts, described Arillus Longan is 4 parts, described chryanthemum parthenium is 6 parts, described Semen Ginkgo is 13 parts, described lavender is 15 parts, described Herba Rosmarini Officinalis is 22 parts, described Folium Artemisiae Argyi is 19 parts, described Rhizoma Chuanxiong is 25 parts, the described Radix Angelicae Dahuricae is 31 parts, the described Radix Paeoniae Alba is 36 parts, described Radix Bupleuri is 28 parts, described Rhizoma Typhonii is 5 parts, described when being classified as 31 parts, described Concha Haliotidis is 35 parts, described Ramulus Uncariae Cum Uncis is 8 parts, the described Rhizoma Pinelliae is 10 parts, described Rhizoma Zingiberis is 18 parts.
In a preferred embodiment of the present invention, each composition of the migrainous Chinese herbal medicine of described treatment by the concrete proportioning of umber is: described in to drive hot chrysanthemum be 12 parts, described Radix Glycyrrhizae Preparata is 18 parts, the described Radix Astragali is 10 parts, described Arillus Longan is 5 parts, described chryanthemum parthenium is 7 parts, described Semen Ginkgo is 14 parts, described lavender is 16 parts, described Herba Rosmarini Officinalis is 23 parts, described Folium Artemisiae Argyi is 20 parts, described Rhizoma Chuanxiong is 26 parts, the described Radix Angelicae Dahuricae is 32 parts, the described Radix Paeoniae Alba is 37 parts, described Radix Bupleuri is 29 parts, described Rhizoma Typhonii is 6 parts, described when being classified as 32 parts, described Concha Haliotidis is 36 parts, described Ramulus Uncariae Cum Uncis is 9 parts, the described Rhizoma Pinelliae is 11 parts, described Rhizoma Zingiberis is 19 parts.
Of the present inventionly for a kind of, treat migrainous Chinese herbal medicine, this product adopts pure natural plant to make, and green non-pollution is used without any side effectsly, and each migrainoid phenomenon is had to good therapeutic effect, regulates function of human body simultaneously.
The specific embodiment
Below preferred embodiment of the present invention is described in detail, thereby so that advantages and features of the invention can be easier to be it will be appreciated by those skilled in the art that, protection scope of the present invention is made to more explicit defining.
Of the present invention is a kind of migrainous Chinese herbal medicine for the treatment of, comprise and drive hot chrysanthemum, chryanthemum parthenium, Semen Ginkgo, lavender, Herba Rosmarini Officinalis, Folium Artemisiae Argyi, Rhizoma Chuanxiong, the Radix Angelicae Dahuricae, the Radix Paeoniae Alba, Radix Bupleuri, Rhizoma Typhonii, Radix Angelicae Sinensis, Concha Haliotidis, Ramulus Uncariae Cum Uncis, the Rhizoma Pinelliae and Rhizoma Zingiberis, each composition of the migrainous Chinese herbal medicine of described treatment by umber proportioning is: described in to drive hot chrysanthemum be 10-13 part, described Radix Glycyrrhizae Preparata is 16-19 part, the described Radix Astragali is 8-11 part, described Arillus Longan is 3-6 part, described chryanthemum parthenium is 5-8 part, described Semen Ginkgo is 12-15 part, described lavender is 14-17 part, described Herba Rosmarini Officinalis is 21-24 part, described Folium Artemisiae Argyi is 18-21 part, described Rhizoma Chuanxiong is 24-27 part, the described Radix Angelicae Dahuricae is 30-33 part, the described Radix Paeoniae Alba is 35-38 part, described Radix Bupleuri is 27-30 part, described Rhizoma Typhonii is 4-7 part, described when being classified as 30-33 part, described Concha Haliotidis is 34-37 part, described Ramulus Uncariae Cum Uncis is 7-10 part, the described Rhizoma Pinelliae is 9-12 part, described Rhizoma Zingiberis is 17-20 part.
Further, each composition of the migrainous Chinese herbal medicine of described treatment by the concrete proportioning of umber is: described in to drive hot chrysanthemum be 11 parts, described Radix Glycyrrhizae Preparata is 17 parts, the described Radix Astragali is 9 parts, described Arillus Longan is 4 parts, described chryanthemum parthenium is 6 parts, described Semen Ginkgo is 13 parts, described lavender is 15 parts, described Herba Rosmarini Officinalis is 22 parts, described Folium Artemisiae Argyi is 19 parts, described Rhizoma Chuanxiong is 25 parts, the described Radix Angelicae Dahuricae is 31 parts, the described Radix Paeoniae Alba is 36 parts, described Radix Bupleuri is 28 parts, described Rhizoma Typhonii is 5 parts, described when being classified as 31 parts, described Concha Haliotidis is 35 parts, described Ramulus Uncariae Cum Uncis is 8 parts, the described Rhizoma Pinelliae is 10 parts, described Rhizoma Zingiberis is 18 parts.
Further, each composition of the migrainous Chinese herbal medicine of described treatment by the concrete proportioning of umber is: described in to drive hot chrysanthemum be 12 parts, described Radix Glycyrrhizae Preparata is 18 parts, the described Radix Astragali is 10 parts, described Arillus Longan is 5 parts, described chryanthemum parthenium is 7 parts, described Semen Ginkgo is 14 parts, described lavender is 16 parts, described Herba Rosmarini Officinalis is 23 parts, described Folium Artemisiae Argyi is 20 parts, described Rhizoma Chuanxiong is 26 parts, the described Radix Angelicae Dahuricae is 32 parts, the described Radix Paeoniae Alba is 37 parts, described Radix Bupleuri is 29 parts, described Rhizoma Typhonii is 6 parts, described when being classified as 32 parts, described Concha Haliotidis is 36 parts, described Ramulus Uncariae Cum Uncis is 9 parts, the described Rhizoma Pinelliae is 11 parts, described Rhizoma Zingiberis is 19 parts.
By the proportioning of different umbers, can regulate the result of use of whole drug effect.
Of the present inventionly for a kind of, treat migrainous Chinese herbal medicine, this product adopts pure natural plant to make, and green non-pollution is used without any side effectsly, and each migrainoid phenomenon is had to good therapeutic effect, regulates function of human body simultaneously.
The foregoing is only the specific embodiment of the present invention; but protection scope of the present invention is not limited to this; any those of ordinary skill in the art are in the disclosed technical scope of the present invention; the variation that can expect without creative work or replacement, within all should being encompassed in protection scope of the present invention.Therefore, protection scope of the present invention should be as the criterion with the protection domain that claims were limited.
Claims (3)
1. treat migrainous Chinese herbal medicine for one kind, it is characterized in that: comprise and drive hot chrysanthemum, chryanthemum parthenium, Semen Ginkgo, lavender, Herba Rosmarini Officinalis, Folium Artemisiae Argyi, Rhizoma Chuanxiong, the Radix Angelicae Dahuricae, the Radix Paeoniae Alba, Radix Bupleuri, Rhizoma Typhonii, Radix Angelicae Sinensis, Concha Haliotidis, Ramulus Uncariae Cum Uncis, the Rhizoma Pinelliae and Rhizoma Zingiberis, each composition of the migrainous Chinese herbal medicine of described treatment by umber proportioning is: described in to drive hot chrysanthemum be 10-13 part, described Radix Glycyrrhizae Preparata is 16-19 part, the described Radix Astragali is 8-11 part, described Arillus Longan is 3-6 part, described chryanthemum parthenium is 5-8 part, described Semen Ginkgo is 12-15 part, described lavender is 14-17 part, described Herba Rosmarini Officinalis is 21-24 part, described Folium Artemisiae Argyi is 18-21 part, described Rhizoma Chuanxiong is 24-27 part, the described Radix Angelicae Dahuricae is 30-33 part, the described Radix Paeoniae Alba is 35-38 part, described Radix Bupleuri is 27-30 part, described Rhizoma Typhonii is 4-7 part, described when being classified as 30-33 part, described Concha Haliotidis is 34-37 part, described Ramulus Uncariae Cum Uncis is 7-10 part, the described Rhizoma Pinelliae is 9-12 part, described Rhizoma Zingiberis is 17-20 part.
2. the migrainous Chinese herbal medicine for the treatment of according to claim 1, it is characterized in that: each composition of the migrainous Chinese herbal medicine of described treatment by the concrete proportioning of umber is: described in to drive hot chrysanthemum be 11 parts, described Radix Glycyrrhizae Preparata is 17 parts, the described Radix Astragali is 9 parts, described Arillus Longan is 4 parts, described chryanthemum parthenium is 6 parts, described Semen Ginkgo is 13 parts, described lavender is 15 parts, described Herba Rosmarini Officinalis is 22 parts, described Folium Artemisiae Argyi is 19 parts, described Rhizoma Chuanxiong is 25 parts, the described Radix Angelicae Dahuricae is 31 parts, the described Radix Paeoniae Alba is 36 parts, described Radix Bupleuri is 28 parts, described Rhizoma Typhonii is 5 parts, described when being classified as 31 parts, described Concha Haliotidis is 35 parts, described Ramulus Uncariae Cum Uncis is 8 parts, the described Rhizoma Pinelliae is 10 parts, described Rhizoma Zingiberis is 18 parts.
3. the migrainous Chinese herbal medicine for the treatment of according to claim 1, it is characterized in that: each composition of the migrainous Chinese herbal medicine of described treatment by the concrete proportioning of umber is: described in to drive hot chrysanthemum be 12 parts, described Radix Glycyrrhizae Preparata is 18 parts, the described Radix Astragali is 10 parts, described Arillus Longan is 5 parts, described chryanthemum parthenium is 7 parts, described Semen Ginkgo is 14 parts, described lavender is 16 parts, described Herba Rosmarini Officinalis is 23 parts, described Folium Artemisiae Argyi is 20 parts, described Rhizoma Chuanxiong is 26 parts, the described Radix Angelicae Dahuricae is 32 parts, the described Radix Paeoniae Alba is 37 parts, described Radix Bupleuri is 29 parts, described Rhizoma Typhonii is 6 parts, described when being classified as 32 parts, described Concha Haliotidis is 36 parts, described Ramulus Uncariae Cum Uncis is 9 parts, the described Rhizoma Pinelliae is 11 parts, described Rhizoma Zingiberis is 19 parts.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410406929.4A CN104127854A (en) | 2014-08-19 | 2014-08-19 | Chinese herbal medicine for treating migraine |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410406929.4A CN104127854A (en) | 2014-08-19 | 2014-08-19 | Chinese herbal medicine for treating migraine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104127854A true CN104127854A (en) | 2014-11-05 |
Family
ID=51800876
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410406929.4A Pending CN104127854A (en) | 2014-08-19 | 2014-08-19 | Chinese herbal medicine for treating migraine |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104127854A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105362469A (en) * | 2015-11-17 | 2016-03-02 | 台耀军 | Traditional Chinese medicine for treating migraine and preparation method thereof |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101156935A (en) * | 2007-03-12 | 2008-04-09 | 北京联合伟华药业有限公司 | Plants active component composition for curing sick headache as well as its preparing method and application |
| CN101732585A (en) * | 2010-01-12 | 2010-06-16 | 四川梓橦宫药业有限公司 | Medicinal composition for treating migraine, preparation method and application thereof |
| CN103054780A (en) * | 2013-01-23 | 2013-04-24 | 中国医学科学院药用植物研究所海南分所 | Chinese medicinal herb fragrant bath formula for nursing and caring skin and resisting aging |
-
2014
- 2014-08-19 CN CN201410406929.4A patent/CN104127854A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101156935A (en) * | 2007-03-12 | 2008-04-09 | 北京联合伟华药业有限公司 | Plants active component composition for curing sick headache as well as its preparing method and application |
| CN101732585A (en) * | 2010-01-12 | 2010-06-16 | 四川梓橦宫药业有限公司 | Medicinal composition for treating migraine, preparation method and application thereof |
| CN103054780A (en) * | 2013-01-23 | 2013-04-24 | 中国医学科学院药用植物研究所海南分所 | Chinese medicinal herb fragrant bath formula for nursing and caring skin and resisting aging |
Non-Patent Citations (2)
| Title |
|---|
| 张冰主编: "《临床中药学》", 30 September 2012 * |
| 张旭德: "加味散偏汤治疗偏头痛临床观察", 《中国社区医师（医学专业）》 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105362469A (en) * | 2015-11-17 | 2016-03-02 | 台耀军 | Traditional Chinese medicine for treating migraine and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3597201A3 (en) | Combination therapy for treatment of patients with neurological disorders and cerebral infarction | |
| CN104127855A (en) | Chinese herbal medicine for treating diarrhea | |
| CN101884761A (en) | Medicament for treating cirrhosis and portal hypertension | |
| CN104116905A (en) | Medicament for treating rhinitis | |
| CN102274395A (en) | Traditional Chinese medicine for treating rhinitis | |
| CN104127854A (en) | Chinese herbal medicine for treating migraine | |
| CN104740131A (en) | Traditional Chinese medicinal oral liquid for treating apoplexy hemiplegia | |
| CN103372083A (en) | Chinese medicinal composition for treating spontaneous perspiration | |
| CN104398915A (en) | Traditional Chinese medicinal composition for chronic eczema | |
| CN104127591A (en) | Chinese herbal medicine for clearing away heat and toxic materials | |
| CN104721791A (en) | Pharmaceutical formulation for treating cardiovascular and cerebrovascular diseases | |
| CN105617303A (en) | Traditional Chinese medicine for pulmonary tuberculosis | |
| CN105012516A (en) | Composition traditional Chinese medicine for treating xerophthalmia | |
| CN103860876A (en) | Essence liquid for treating hepatitis B | |
| CN103877369A (en) | Hepatitis B treatment compound | |
| CN103394023A (en) | Traditional Chinese medicine used for treating viral hepatitis A | |
| WO2017220047A3 (en) | Formulation treating joint ache | |
| CN104383456A (en) | Traditional Chinese medicine composition for treating costal chondritis | |
| CN105267693A (en) | Traditional Chinese medicine prescription for internal use in treating osteoarthritis | |
| CN106138587A (en) | A kind of Chinese herbal medicine treating qi depression to blood stasis pain | |
| CN104922479A (en) | Traditional Chinese medicinal preparation for treating cerebrovascular disease | |
| CN104721797A (en) | Ointment for treating frostbite | |
| CN104491141A (en) | Traditional Chinese medicine composition for treating blood stasis | |
| CN105267621A (en) | Combined traditional Chinese medicine for treating dry and rough skins | |
| CN102370841A (en) | Chinese herbal prescription for treating stagnation of qi due to depression of liver in later menstrual period |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20141105 |